Researchers from Clínic-IDIBAPS, as part of the Clínic Barcelona Comprehensive Cancer Centre — a centre driven by Clínic, IDIBAPS and the Universit...
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
CAR T-cell therapy, a revolutionary technology originally developed for blood cancers, may also help in restoring the immune system in severe autoi...
On Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held its inaugural meeting on...
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapie...
The prognosis for patients with systemic lupus erythematosus (SLE) has improved dramatically over the last 50 years. Thus, from a 5-year mortality...
The campaign’s challenge was to collect 12,000 book reviews, and it exceeded its goal. A total of 15,399 reviews were received.
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regul...
